STOCK TITAN

Cresco Labs Expands Sunnyside in Pennsylvania with 11th New Store

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cresco Labs (OTCQX:CRLBF) has expanded its retail presence to 57 locations with the opening of its 11th dispensary in Pennsylvania, located in Erie. This new Sunnyside location features a drive-through service for medical patients. CEO Charles Bachtell highlighted that Cresco has maintained its status as the top branded portfolio for medical patients in Pennsylvania throughout 2022. With licenses for four more stores in the state, the company aims to enhance patient access to its high-quality products. The Erie dispensary is strategically placed for increased accessibility, near major retailers and on Interstate 90.

Positive
  • Expansion to 57 locations nationwide, indicating growth.
  • Sunnyside Erie features a drive-through, enhancing convenience for patients.
  • Maintain top position in Pennsylvania's branded portfolio for medical patients throughout 2022.
  • Licenses obtained for four additional stores to further increase market presence.
Negative
  • None.

CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced its retail footprint grew to 57 locations nationwide with today’s Sunnyside opening in Erie, PA. Sunnyside Erie, located at 7851 Peach St., marks the Company’s 11th dispensary in the state.

Cresco Labs opened its 11th Pennsylvania dispensary in Erie under its Sunnyside brand. (Photo: Business Wire)

Cresco Labs opened its 11th Pennsylvania dispensary in Erie under its Sunnyside brand. (Photo: Business Wire)

“We’re thrilled to build on our retail and wholesale success in Pennsylvania by expanding the Sunnyside brand in northern Pennsylvania,” said Charles Bachtell, Cresco Labs’ CEO & Co-Founder. “We’ve maintained our position in the state as the number one branded portfolio chosen by medical patients for all of 2022. With licenses to open four additional stores, we’ll continue to go deep in Pennsylvania to increase patient access to our top-quality products.”

Sunnyside Erie is the Company’s first dispensary in Pennsylvania to offer a drive through to give medical patients a safe and more convenient way to shop. The dispensary is strategically located in a major retail corridor near big box retailers like Walmart and Home Depot and off Interstate 90 for increased accessibility.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Sunday through Thursday, 9 AM to 6 PM, and Friday and Saturday, 9 AM to 7 PM.

Cresco Labs operates 11 Sunnyside stores in Pennsylvania: Butler, Philadelphia (Chestnut St. and City Ave.), New Kensington, Pittsburgh, Wyomissing, Ambler, Lancaster, Phoenixville, Montgomeryville and Erie.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Twitter: Cresco Labs

LinkedIn: Cresco Labs

Media:

Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:

Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:

312-929-0993

info@crescolabs.com

Source: Cresco Labs

CRESCO LABS INC

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

374.59M
271.34M
0.66%
5.5%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago